Enveric Biosciences Inc

NASDAQ: ENVB
$0.93
+$0.04 (+4.1%)
Closing price April 24, 2024
Enveric Biosciences, Inc., a pharmaceutical company, is dedicated to developing various cannabinoid drugs for the treatment of cancer. The company is headquartered in Naples, Florida.

Time to Buy the Magic Stocks? Magic Mushrooms, That Is.
Here's a quick look at six publicly traded companies developing ways to use psychedelics to treat mental health issues.
Paul Ausick
Published: